AEHR Reports Steep Q3 Revenue Decline and Widened Losses; Completes $40M ATM Offering Amidst Ongoing IP Dispute

summarizeSummary

AEHR Test Systems reported a significant year-over-year decline in Q3 revenue and a substantial increase in net losses, alongside notable gross margin compression, despite fully utilizing its $40 million At-The-Market offering for liquidity.

check_boxKey Events

• Significant Revenue Decline and Widened Losses

  For the three months ended February 27, 2026, revenue decreased 43.7% year-over-year to $10.3 million, and net loss widened to $3.2 million from $0.6 million in the prior year. Year-to-date, revenue fell 30.6% to $31.2 million, with net loss increasing to $8.5 million from $1.0 million.

• Gross Margin Compression

  Gross margin declined by 6.5 percentage points in Q3 and 12.9 percentage points year-to-date, primarily due to a shift towards lower-margin package-level burn-in products and higher assembly, warranty, freight, and tariff costs.

• Completion of $40 Million ATM Offering

  The company fully utilized its $40 million At-The-Market (ATM) offering program, selling 476,649 shares in March 2026 for $19.5 million, following earlier sales of $10.0 million in November 2025 and $10.5 million in February 2026. This provides significant liquidity but is dilutive.

• Ongoing IP Litigation in China

  The company is appealing a first-instance judgment that dismissed its intellectual property infringement claims against Suzhou Semight Instruments Co., Ltd. in China, with Semight filing another invalidation petition.

auto_awesomeAnalysis

AEHR Test Systems' latest 10-Q reveals a significant deterioration in financial performance, with Q3 revenue dropping 43.7% year-over-year and net losses widening substantially. This negative trend is further reflected in a notable compression of gross margins. While the company successfully completed its $40 million At-The-Market (ATM) offering, providing crucial liquidity, this capital raise is dilutive and underscores the need for funding amidst operational challenges. The ongoing intellectual property litigation in China, with an unfavorable initial judgment and subsequent appeal, adds a layer of uncertainty and risk. Investors should be concerned about the sustained decline in core business metrics, despite the recent positive news regarding bookings, as the detailed financials paint a more challenging picture.